As a result, preclinical studies have investigated APOE4’s role on potential mechanisms that may be linked with this non-motor symptom in PD and DLB (Dickson et al., 2018; Davis et al., 2020; Zhao et al., 2020). The gene discussed is APOE; the disease is Parkinson disease.